Bayer Healthcare and USAID Launch Microgyon Fe Oral Contraceptive In Nigeria (Photos)

Microgynon® Fe is now available in local pharmacies at a significantly lower price after it’s recent launch in Sheraton Hotels Abuja. The product comes as a result of an innovative public-private partnership between Bayer HealthCare and the United States Agency for International Development (USAID).

The Microgynon® brand is the world’s most widely used oral contraceptive. The reduced price enables middle-income couples to access a quality, affordable family planning product. More Photos after the cut........

The partnership is designed to make more affordable family planning choices available to women through the private sector and address the growing demand for contraceptives and the overall sustainability of supply. Family planning allows couples to plan their families as they desire, reduces the risks from unintended and/or high-risk pregnancies, and improves the health of mothers and their children by allowing time between pregnancies.

The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 19.97 billion (2014), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activity of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer Healthcare’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56, 700 employees (Dec 31, 2014) and is represented in more than 100 countries.